Clinical Trial Update: Mesenchymal Stromal Cells for Degenerative Meniscus Injury [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating mesenchymal stromal cells for chronic meniscal injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meniscal Injury

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: Banc de Sang i Teixits | Conditions: Chronic Meniscal Injury | Phase 1, Phase 2 | Status: COMPLETED